Skip to content
Company
About
Leadership
Board Members
Scientific Advisory Board
Pipeline
Overview
Immuno-Oncology and shedding blockers
BND-22
BND-35
BND-67
Clinical Trials
News
Public Relations
Events
Coverage
Publications
Collaborations
Contact Us
Company
About
Leadership
Board Members
Scientific Advisory Board
Pipeline
Overview
Immuno-Oncology and shedding blockers
BND-22
BND-35
BND-67
Clinical Trials
News
Public Relations
Events
Coverage
Publications
Collaborations
Contact Us
Company
About
Leadership
Board Members
Scientific Advisory Board
Pipeline
Overview
Immuno-Oncology and shedding blockers
BND-22
BND-35
BND-67
Clinical Trials
News
Public Relations
Events
Coverage
Publications
Collaborations
Contact Us
Company
About
Leadership
Board Members
Scientific Advisory Board
Pipeline
Overview
Immuno-Oncology and shedding blockers
BND-22
BND-35
BND-67
Clinical Trials
News
Public Relations
Events
Coverage
Publications
Collaborations
Contact Us
Coverage
JPM: Sanofi pays $125M to take lead in new checkpoint inhibitor space
fiercebiotech / Jan 12, 2021
Biond Biologics sells cancer drug rights to Sanofi for $125m
globes / Jan 12, 2021
Biond Biologics And Sanofi Enter Into Global Licensing Agreement $125 Million Upfront And Over $1 Billion In Milestone And Royalty Payments
goodwin / Jan 12, 2021
Sanofi Keeps on Rolling With Biond Biologics Partnership
biospace / Jan 12, 2021
